Screening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines – pilot study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries201868639442410.3322/caac.2149230207593Open DOISearch in Google Scholar
Zadnik V, Žagar T. SLORA: Slovenia and cancer. Epidemiology and cancer registry. Institute of Oncology Ljubljana. Accessed October 22nd, 2019 at: www.slora.siZadnikVŽagarTAccessed October 22nd2019www.slora.sSearch in Google Scholar
National breast cancer screening programme - DORA. Accessed August 13th, 2018 at: https://dora.onko-i.si/Accessed August 13th2018https://dora.onko-i.si/Search in Google Scholar
Krajc M. National breast cancer screening programme – DORA: residential public health thesis. Ljubljana: Institute of Oncology, 2009.KrajcMLjubljanaInstitute of Oncology2009Search in Google Scholar
Rules on carrying out preventive health care at the primary level. Official Gazette RS. 19/1998, 47/1998, 26/2000, 67/2001, 33/2002, 37/2003, 117/2004, 31/2005, 83/2007, 22/2009, 17/2015, 47/2018, 57/2018, 57/2018.Rules on carrying out preventive health care at the primary level19/1998, 47/1998, 26/2000, 67/2001, 33/2002, 37/2003, 117/2004, 31/2005, 83/2007, 22/2009, 17/2015, 47/2018, 57/2018, 57/2018Search in Google Scholar
Hertl K. Analiza kakovosti mamografskega presejanja v Zdravstvenem domu Domžale v obdobju 1998-2002: master thesis. Ljubljana: 2004.HertlKLjubljana2004Search in Google Scholar
Blatnik A, Perhavec A, Gazić B, Vidergar – Kralj B, Matos E, Ratoša I, et al. Guidelines of breast cancer diagnosis and treatment. Ljubljana: Institute of Oncology, 2018. Accessed October 20th, 2019 at: https://www.onko-i.si/fileadmin/onko/datoteke/Smernice/Smernice_diagnostike_in_zdravljenja_raka_dojk_2018.pdfBlatnikAPerhavecAGazićBVidergar– Kralj BMatosERatošaIet alLjubljanaInstitute of Oncology2018Accessed October 20th, 2019 athttps://www.onko-i.si/fileadmin/onko/datoteke/Smernice/Smernice_diagnostike_in_zdravljenja_raka_dojk_2018.pdfSearch in Google Scholar
Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102(10):680-91. doi: 10.1093/jnci/djq088.AmirEFreedmanOCSerugaBEvansDGAssessing women at high risk of breast cancer: a review of risk assessment models2010102106809110.1093/jnci/djq08820427433Open DOISearch in Google Scholar
Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat. 1993;28(2):115-20. doi: 10.1007/bf00666424.ClausEBRischNThompsonWDThe calculation of breast cancer risk for women with a first degree family history of ovarian cancer19932821152010.1007/bf00666424Open DOISearch in Google Scholar
Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer. 1994;73(3):643-51. doi: 10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5.ClausEBRischNThompsonWDAutosomal dominant inheritance of early-onset breast cancer: implications for risk prediction19947336435110.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-510.1097/00006254-199406000-00016Search in Google Scholar
Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-86. doi: 10.1093/jnci/81.24.1879.GailMHBrintonLAByarDPCorleDKGreenSBSchairerCet alProjecting individualized probabilities of developing breast cancer for white females who are being examined annually1989812418798610.1093/jnci/81.24.18792593165Open DOISearch in Google Scholar
Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358-66. doi: 10.1093/jnci/93.5.358.RockhillBSpiegelmanDByrneCHunterDJColditzGAValidation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention20019353586610.1093/jnci/93.5.35811238697Open DOISearch in Google Scholar
Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst. 1994;86(8):600-7. doi: 10.1093/jnci/86.8.600.SpiegelmanDColditzGAHunterDHertzmarkEValidation of the Gail et al. model for predicting individual breast cancer risk1994868600710.1093/jnci/86.8.6008145275Open DOISearch in Google Scholar
Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat. 2005;94(2):115-22. doi: 10.1007/s10549-005-5152-4.TiceJACummingsSRZivEKerlikowskeKMammographic breast density and the Gail model for breast cancer risk prediction in a screening population20059421152210.1007/s10549-005-5152-416261410Open DOISearch in Google Scholar
Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer. 2008;98(8):1457-66. doi: 10.1038/sj.bjc.6604305.AntoniouACCunninghamAPPetoJEvansDGLallooFNarodSAet alThe BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions200898814576610.1038/sj.bjc.6604305236171618349832Open DOISearch in Google Scholar
Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer. 2004;91(8):1580-90. doi: 10.1038/sj.bjc.6602175.AntoniouACPharoahPPSmithPEastonDFThe BOADICEA model of genetic susceptibility to breast and ovarian cancer200491815809010.1038/sj.bjc.6602175240993415381934Open DOISearch in Google Scholar
Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111-30. doi: 10.1002/sim.1668.TyrerJDuffySWCuzickJA breast cancer prediction model incorporating familial and personal risk factors200423711113010.1002/sim.166815057881Open DOISearch in Google Scholar
Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. Br J Cancer. 2014;110(2):535-45. doi: 10.1038/bjc.2013.730.LeeAJCunninghamAPKuchenbaeckerKBMavaddatNEastonDFAntoniouACBOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface201411025354510.1038/bjc.2013.730389976624346285Open DOISearch in Google Scholar
Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat. 2019;175(2):519-523. doi: 10.1007/s10549-019-05167-2.TiceJABissellMCSMigliorettiDLGardCCRauscherGHDabbousFMet alValidation of the breast cancer surveillance consortium model of breast cancer risk2019175251952310.1007/s10549-019-05167-2713802530796654Open DOISearch in Google Scholar
Zadnik V, Krajc M. Razvoj in implementacija orodja za določanje individualne ogroženosti z rakom dojk v slovenski populaciji. Onkologija. 2018;22(2):6-10.ZadnikVKrajcMRazvoj in implementacija orodja za določanje individualne ogroženosti z rakom dojk v slovenski populaciji2018222610Search in Google Scholar
Simonović S. Pilot testing of S-IBIS at the Breast Unit Kranj: residential public health thesis, 2017.SimonovićS2017Search in Google Scholar
Leskovec M. Individualised breast cancer risk assessement with S-IBIS at the primary health level: master thesis. Izola: University of Primorska, Faculty of Health Sciences, 2018.LeskovecMIzolaUniversity of Primorska, Faculty of Health Sciences2018Search in Google Scholar
Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40(11):807-14. doi: 10.1136/jmg.40.11.807.AmirEEvansDGShentonALallooFMoranABoggisCet alEvaluation of breast cancer risk assessment packages in the family history evaluation and screening programme200340118071410.1136/jmg.40.11.807173531714627668Open DOISearch in Google Scholar
Anderson H, Bladstrom A, Olsson H, Moller TR. Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol. 2000;152(12):1154-63. doi: 10.1093/aje/152.12.1154.AndersonHBladstromAOlssonHMollerTRFamilial breast and ovarian cancer: a Swedish population-based register study20001521211546310.1093/aje/152.12.115411130621Open DOISearch in Google Scholar
International Breast Cancer Intervention Study – IBIS. Accessed March 8th, 2019 at: https://ibis.ikonopedia.com/Accessed March 8th2019https://ibis.ikonopedia.com/Search in Google Scholar
Armstrong AC, Evans GD. Management of women at high risk of breast cancer. BMJ. 2014;348:g2756. doi: 10.1136/bmj.g2756.ArmstrongACEvansGDManagement of women at high risk of breast cancer2014348g275610.1136/bmj.g275624778341Open DOISearch in Google Scholar
National institute of health and clinical excellence (NICE), 2013. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risk in people with a family history of breast cancer. Accessed December 8th, 2019 at: http://www.nice.org.uk/guidance/cg164/evidence/full-guideline-190130941Accessed December 8th, 2019 athttp://www.nice.org.uk/guidance/cg164/evidence/full-guideline-190130941Search in Google Scholar
Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, et al. Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res (Phila). 2014;7(10):993-1001. doi: 10.1158/1940-6207.CAPR-14-0037.EvansDGBrentnallARHarvieMDaweSSergeantJCStavrinosPet alBreast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention2014710993100110.1158/1940-6207.CAPR-14-003725047362Open DOISearch in Google Scholar
ECIS - European Cancer Information System. European Commission. Accessed March 8th, 2019 at: https://ecis.jrc.ec.europa.eu/explorer.phpAccessed March 8th2019https://ecis.jrc.ec.europa.eu/explorer.phpSearch in Google Scholar
Evans DG, Ingham S, Dawe, S Roberts L, Lalloo F, Brentnall AR, et al. Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme. Fam Cancer. 2014;13(2):189-96. doi: 10.1007/s10689-013-9694-z.EvansDGInghamSRoberts LSLallooFBrentnallARet alBreast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme20141321899610.1007/s10689-013-9694-z24276527Open DOISearch in Google Scholar